{"id":3601,"date":"2018-01-23T15:06:56","date_gmt":"2018-01-23T15:06:56","guid":{"rendered":"https:\/\/kess2.ac.uk\/?p=3601"},"modified":"2018-02-26T12:20:28","modified_gmt":"2018-02-26T12:20:28","slug":"pet-labelled-probes-for-cancer-patient-stratification","status":"publish","type":"post","link":"https:\/\/kess2.ac.uk\/cy\/pet-labelled-probes-for-cancer-patient-stratification\/","title":{"rendered":"Chwiliedydd \u00e2 labeli PET ar gyfer Haenu Cleifion Canser"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-3925\" src=\"https:\/\/kess2.ac.uk\/wp-content\/uploads\/Roderick-Stark.png\" alt=\"Roderick Stark\" width=\"200\" height=\"200\" srcset=\"https:\/\/kess2.ac.uk\/wp-content\/uploads\/Roderick-Stark.png 200w, https:\/\/kess2.ac.uk\/wp-content\/uploads\/Roderick-Stark-150x150.png 150w, https:\/\/kess2.ac.uk\/wp-content\/uploads\/Roderick-Stark-125x125.png 125w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/>Myfyriwr:\u00a0<\/strong>Roderick Stark<br \/>\n<strong>Goruchwyliwr:<\/strong>\u00a0Dr Ian Fallis<br \/>\n<strong>Lleoliad:\u00a0<\/strong>Prifysgol Caerdydd<br \/>\n<strong>Math o Ganser:\u00a0<\/strong>Pob un &#8211; Triniaeth canser<br \/>\n<strong>Dyddiad dechrau a gorffen:\u00a0<\/strong>Hydref 2016 &#8211; Medi 2019<\/p>\n<p>Bydd y gwaith hwn yn berthnasol yn glinigol yn y dyfodol oherwydd gan fod yr olinyddion arfaethedig union yr un fath yn glinigol \u00e2 gemcitabin a\u2019i analogau pro-gyffuriau, bydd y nifer sy\u2019n derbyn biobrofion PET yn arwydd uniongyrchol o addasrwydd yr asiantau hyn yn y driniaeth i glaf unigol. Byddai hyn yn gam pwysig tuag at ofal canser wedi&#8217;i bersonoli a\u2019i hwyluso gan sgan unigol heb lawdriniaeth.<\/p>\n<p><a href=\"https:\/\/kess2.ac.uk\/cy\/case-studies\/current-kess-2-projects-in-partnership-with-tenovus-cancer-care\/\"><strong>&lt;&lt; Yn \u00f4l<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Myfyriwr:\u00a0Roderick Stark Goruchwyliwr:\u00a0Dr Ian Fallis Lleoliad:\u00a0Prifysgol Caerdydd Math o Ganser:\u00a0Pob un &#8211; Triniaeth canser Dyddiad dechrau a gorffen:\u00a0Hydref 2016 &#8211; Medi 2019 Bydd y gwaith hwn yn berthnasol yn glinigol yn y dyfodol oherwydd gan fod yr olinyddion arfaethedig union yr un fath yn glinigol \u00e2 gemcitabin a\u2019i analogau pro-gyffuriau, bydd y nifer sy\u2019n derbyn&#8230;  <a class=\"excerpt-read-more\" href=\"https:\/\/kess2.ac.uk\/cy\/pet-labelled-probes-for-cancer-patient-stratification\/\" title=\"DarllenChwiliedydd \u00e2 labeli PET ar gyfer Haenu Cleifion Canser\">Darllen mwy &raquo;<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[332],"tags":[],"class_list":["post-3601","post","type-post","status-publish","format-standard","hentry","category-tenovus-cancer-care"],"_links":{"self":[{"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/posts\/3601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/comments?post=3601"}],"version-history":[{"count":4,"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/posts\/3601\/revisions"}],"predecessor-version":[{"id":3926,"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/posts\/3601\/revisions\/3926"}],"wp:attachment":[{"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/media?parent=3601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/categories?post=3601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kess2.ac.uk\/cy\/wp-json\/wp\/v2\/tags?post=3601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}